USD 0.95
(2.1%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 73.06 Million USD | 50.29% |
2022 | 48.5 Million USD | -24.48% |
2021 | 64.23 Million USD | -71.47% |
2020 | 225.15 Million USD | 926.35% |
2019 | -27.24 Million USD | -114.79% |
2018 | 184.2 Million USD | 71498.84% |
2017 | -258 Thousand USD | -2.38% |
2016 | -252 Thousand USD | -6.78% |
2015 | -236 Thousand USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 4.97 Billion USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 100.0% |
2000 | -784 Thousand USD | -14.75% |
1999 | -683.22 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 58.21 Million USD | -54.4% |
2024 Q1 | 127.66 Million USD | 513.99% |
2023 FY | 72.9 Million USD | 50.29% |
2023 Q1 | 12.67 Million USD | -13.51% |
2023 Q4 | 20.79 Million USD | 0.97% |
2023 Q2 | 19 Million USD | 49.88% |
2023 Q3 | 20.59 Million USD | 8.38% |
2022 FY | 48.5 Million USD | -24.48% |
2022 Q4 | 14.65 Million USD | 17.51% |
2022 Q3 | 12.47 Million USD | 29.06% |
2022 Q2 | 9.66 Million USD | -17.47% |
2022 Q1 | 11.71 Million USD | 13.41% |
2021 Q4 | 10.32 Million USD | 16.66% |
2021 Q3 | 8.85 Million USD | -77.22% |
2021 Q2 | 38.85 Million USD | 527.37% |
2021 Q1 | 6.19 Million USD | -22.09% |
2021 FY | 64.23 Million USD | -71.47% |
2020 Q1 | 1.8 Million USD | 104.86% |
2020 FY | 225.15 Million USD | 926.35% |
2020 Q3 | 3.55 Million USD | -98.32% |
2020 Q4 | 7.95 Million USD | 123.44% |
2020 Q2 | 211.83 Million USD | 11610.23% |
2019 Q4 | -37.25 Million USD | 21.24% |
2019 Q1 | 99.11 Million USD | -26.58% |
2019 Q2 | -41.8 Million USD | -142.18% |
2019 Q3 | -47.3 Million USD | -13.14% |
2019 FY | -27.24 Million USD | -114.79% |
2018 Q2 | -39.52 Million USD | 3.46% |
2018 FY | 184.2 Million USD | 71498.84% |
2018 Q1 | -40.94 Million USD | 72.26% |
2018 Q4 | 135 Million USD | 424.9% |
2018 Q3 | -41.55 Million USD | -5.13% |
2017 Q1 | - USD | 0.0% |
2017 FY | -258 Thousand USD | -2.38% |
2017 Q4 | -147.6 Million USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | -252 Thousand USD | -6.78% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | -236 Thousand USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | -100.0% |
2014 Q2 | - USD | 0.0% |
2013 FY | 4.97 Billion USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2001 Q2 | -741 Thousand USD | -3.78% |
2001 FY | - USD | 100.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 100.0% |
2001 Q1 | -714 Thousand USD | -244.53% |
2000 Q2 | -428 Thousand USD | -5.93% |
2000 Q1 | -404.05 Thousand USD | 0.0% |
2000 Q3 | -444 Thousand USD | -3.74% |
2000 Q4 | 494 Thousand USD | 211.26% |
2000 FY | -784 Thousand USD | -14.75% |
1999 FY | -683.22 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aquestive Therapeutics, Inc. | 29.75 Million USD | -145.587% |
Collegium Pharmaceutical, Inc. | 326.16 Million USD | 77.598% |
Journey Medical Corporation | 52.52 Million USD | -39.12% |
Dynavax Technologies Corporation | 182.11 Million USD | 59.879% |
Intra-Cellular Therapies, Inc. | 430.62 Million USD | 83.032% |
Pacira BioSciences, Inc. | 490.3 Million USD | 85.098% |
PainReform Ltd. | -15 Thousand USD | 487213.333% |
Petros Pharmaceuticals, Inc. | 4.19 Million USD | -1643.357% |
Sunshine Biopharma, Inc. | 8.33 Million USD | -776.19% |
Sunshine Biopharma, Inc. | 8.33 Million USD | -776.19% |
SCYNEXIS, Inc. | 124.51 Million USD | 41.32% |
Silver Spike Investment Corp. | 8.1 Million USD | -801.772% |
China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -13089.68% |
Alpha Teknova, Inc. | 10.29 Million USD | -609.664% |
Alvotech | -69.42 Million USD | 205.25% |
ANI Pharmaceuticals, Inc. | 305.3 Million USD | 76.067% |
Bright Green Corporation | -237.01 Thousand USD | 30927.877% |
Embecta Corp. | 749.9 Million USD | 90.256% |
Safety Shot Inc | -74.45 Thousand USD | 98233.151% |
Procaps Group, S.A. | 239.56 Million USD | 69.501% |
Cosmos Health Inc. | 4.34 Million USD | -1579.868% |
Theratechnologies Inc. | 62.12 Million USD | -17.605% |
Harrow Health, Inc. | 90.55 Million USD | 19.31% |
Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -1439.874% |
Biofrontera Inc. | 16.62 Million USD | -339.448% |
DURECT Corporation | 6.83 Million USD | -969.638% |
Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 86.049% |
Cronos Group Inc. | 6.99 Million USD | -945.174% |
OptiNose, Inc. | 62.35 Million USD | -17.181% |
Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 83.438% |
Kala Pharmaceuticals, Inc. | -303 Thousand USD | 24214.521% |
RedHill Biopharma Ltd. | 3.05 Million USD | -2292.366% |
Organogenesis Holdings Inc. | 309.79 Million USD | 76.414% |
Guardion Health Sciences, Inc. | 5.39 Million USD | -1254.468% |
Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -118.202% |
Radius Health, Inc. | 307.71 Million USD | 76.255% |
Universe Pharmaceuticals INC | 10.07 Million USD | -625.024% |
ProPhase Labs, Inc. | 16.23 Million USD | -349.948% |
Phibro Animal Health Corporation | 312.48 Million USD | 76.618% |
Procaps Group S.A. | 239.56 Million USD | 69.501% |
TherapeuticsMD, Inc. | 1.3 Million USD | -5511.905% |
Viatris Inc. | 6.43 Billion USD | 98.865% |
Rockwell Medical, Inc. | 8.7 Million USD | -739.465% |
Aytu BioPharma, Inc. | 54.58 Million USD | -33.857% |
SIGA Technologies, Inc. | 122.09 Million USD | 40.154% |
Tilray Brands, Inc. | 223.35 Million USD | 67.286% |
Lifecore Biomedical, Inc. | 41.85 Million USD | -74.593% |
Shineco, Inc. | 882.16 Thousand USD | -8182.663% |
PetIQ, Inc. | 252.74 Million USD | 71.09% |
Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 9899.916% |
Incannex Healthcare Limited | 12 Thousand USD | -608791.667% |
Neurocrine Biosciences, Inc. | 1.84 Billion USD | 96.045% |
Alimera Sciences, Inc. | 61.17 Million USD | -19.449% |
Assertio Holdings, Inc. | 125.04 Million USD | 41.569% |
Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 1072879.328% |
Clever Leaves Holdings Inc. | 6.55 Million USD | -1014.506% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 3131.604% |
Avadel Pharmaceuticals plc | 27.11 Million USD | -169.451% |
Hempacco Co., Inc. | -1.21 Million USD | 6109.625% |
Talphera, Inc. | -4.89 Million USD | 1592.686% |
Alvotech | -69.42 Million USD | 205.25% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 67.039% |
Lantheus Holdings, Inc. | 709.54 Million USD | 89.702% |
Currenc Group, Inc. | 17.35 Million USD | -320.982% |
Kamada Ltd. | 52.59 Million USD | -38.93% |
Indivior PLC | 907 Million USD | 91.944% |
Evoke Pharma, Inc. | 4.97 Million USD | -1367.577% |
Flora Growth Corp. | 17.73 Million USD | -311.924% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 3131.604% |
Evolus, Inc. | 140.52 Million USD | 48.005% |
HUTCHMED (China) Limited | 453.55 Million USD | 83.89% |
Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 78.758% |
Akanda Corp. | 111.44 Thousand USD | -65460.929% |